Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NF1 gene analysis based on DHPLC.

Alessandro De Luca1, Anna Buccino, Debora Gianni

  • 1IRCCS-CSS, San Giovanni Rotondo and CSS-Mendel Institute, Rome, Italy.

Human Mutation
|January 29, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generation and characterization of the hiPSC line CSSi023-A (16154) from a patient with ADOA caused by an OPA1 variant.

Stem cell research·2026
Same author

Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026
Same author

The 9th International RASopathies Symposium.

American journal of medical genetics. Part A·2026
Same author

Intrafamilial Phenotypic Variability in SCA17 with Reduced-Penetrance TBP Expansions.

Cerebellum (London, England)·2026
Same author

Analysis of a Real-World Population Participating in a Cardiac Rehabilitation Program: Cognitive Impairment, Functional Capacity, and Therapy Titration.

Journal of clinical medicine·2026
Same author

Domain-specific phenotypic profiles in RAF1-related Noonan syndrome.

European journal of human genetics : EJHG·2026

Denaturing high-performance liquid chromatography (DHPLC) effectively detects mutations in the NF1 gene. This sensitive method identified 72.5% of mutations in 40 patients, including novel variants, aiding in neurofibromatosis type 1 diagnosis.

Area of Science:

  • Genetics
  • Molecular Biology
  • Biochemistry

Background:

  • The NF1 gene exhibits a high mutation rate, leading to diverse molecular abnormalities, often private and rare.
  • Identifying these mutations is crucial for diagnosing neurofibromatosis type 1 (NF1).

Purpose of the Study:

  • To evaluate the efficacy of denaturing high-performance liquid chromatography (DHPLC) for detecting mutations in the NF1 gene.
  • To screen a cohort of NF1 patients for mutations using DHPLC.

Main Methods:

  • DHPLC, a sensitive technique detecting heteroduplexes in PCR products, was optimized using WAVEmaker software for all NF1 coding exons and splice junctions.
  • A panel of 40 genetically uncharacterized NF1 patients (25 sporadic, 15 familial) were screened for mutations.

Related Experiment Videos

Main Results:

  • DHPLC identified disruptive mutations in 29 out of 40 patients, achieving a 72.5% mutation detection rate.
  • The identified mutations included deletions, insertions, nonsense mutations, missense mutations, splice errors, and a complex rearrangement.
  • Eighteen (62%) of the detected disruptive mutations were novel, alongside unclassified variants and known polymorphisms.

Conclusions:

  • DHPLC is an accurate and rapid method for identifying NF1 gene mutations.
  • The study highlights the utility of DHPLC in genetic diagnostics for neurofibromatosis type 1.
  • The high rate of novel mutations underscores the genetic complexity of NF1.